Stocks
MoonLake’s Sonelokimab Faces Regulatory, Commercial Tests, RBC Says
MoonLake Immunotherapeutics' investigational drug, sonelokimab, is reportedly facing significant regulatory and commercial scrutiny, according to analysis by RBC.
Financial Team 716 articles
Stocks
Tech Selloff Intensifies, Volatility Climbs
Market observers are closely monitoring trending stocks as a significant tech sector selloff deepens, leading to heightened market volatility this week.
Stocks
Tech Plunge Drags Indexes Lower: Nasdaq 100 Falls 2.50%
U.S. stock indexes finished sharply lower Friday, led by a significant -2.50% drop in the Nasdaq 100. The S&P 500 fell -1.09%,...
Stocks
Soybean Futures Trim Losses as Midday Buyers Emerge
Soybean contracts are paring early near double-digit losses on Friday, down 1 to 3 cents at midday. The cmdtyView national average Cash...
Stocks
Anthropic Co-founder Clark Forecasts $44T US GDP by 2030, Citing AI Impact
Anthropic co-founder Clark projects U.S. GDP to reach $44 trillion by 2030, attributing this significant growth directly to advancements in artificial intelligence.
Stocks
Alcon’s Brytly Eye Drops Secure Over-the-Counter Approval
Alcon has announced the over-the-counter approval of its Brytly eye drops, marking a strategic expansion in its product portfolio and market reach.
Stocks
Brent Crude Hits $110, WTI Tops $100: First Since May
Brent crude oil futures have reached $110 per barrel for the first time since May, while U.S. WTI crude has climbed above...
Stocks
Cattle Futures Climb, Cash Market Strengthens
Live cattle futures saw notable gains on Friday, with contracts rising $1.10 to $1.65. This rally was supported by firm cash prices...
Stocks
Cotton Futures Close Mixed, December Contract Drops 54 Points
Cotton futures ended the week with mixed trade on Friday, though the December contract saw a 54-point weekly decline. Crude oil rose,...